The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders
Clinical trial NCT03166098 · COMPLETED
Trial details
- NCT number
- NCT03166098
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-05
- Primary completion
- 2022-03-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.